Access cutting-edge irritable bowel syndrome treatment through this clinical trial at a research site in Corona. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Corona location
Access irritable bowel syndrome specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related irritable bowel syndrome treatment provided free
Check if you qualify for this irritable bowel syndrome clinical trial in Corona, CA
No-Cost Study Care
Local to Corona
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The primary objectives of this study are to explore the therapeutic effect of eluxadoline in treating irritable bowel syndrome with diarrhea (IBS-D) in pediatric participants 6-17 years of age, to evaluate the pharmacokinetics of eluxadoline in pediatric participants with IBS-D, and to evaluate the safety and tolerability of eluxadoline in pediatric participants with IBS-D. Enrollment of 12-17 years old age group is closed, enrollment of the 6-11 years old age group will continue.
Sponsor: AbbVie
Yes, this clinical trial (NCT03339128) has an active research site in Corona, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for irritable bowel syndrome treatment options in Corona, CA, this clinical trial (NCT03339128) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Corona research site is actively enrolling participants for this clinical trial. You'll receive care from experienced irritable bowel syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all irritable bowel syndrome clinical trials near you to find additional studies recruiting in your area.
See all ibs clinical trials recruiting in Corona — not just this study.
Browse IBS Trials in Corona →